Belite Bio Inc - Adr (BLTE) Technical Analysis
$171.54▲0.99%
Market is closed - opens 7 PM, 07 Apr 2026
Insights
- Belite Bio- Adr is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Belite Bio- Adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Belite Bio- Adr stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Belite Bio- Adr stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 55.54 | Neutral |
Stochastic | 78.61, 67.99 | Neutral |
Ultimate Oscillator | 57.87 | Neutral |
Stochastic Relative Strength Index | 100.0, 74.49 | Neutral |
Moving Average Convergence Divergence | -3.32, -4.64 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 155.86 | Sell |
20 | 161.99 | Sell |
50 | 170.81 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 160.09 | Sell |
20 | 162.25 | Sell |
50 | 164.25 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 156.22 | Buy |
20 | 161.31 | Buy |
50 | 171.96 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 160.11 | Buy |
20 | 157.32 | Sell |
50 | 168.49 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 164.34 | Buy |
20 | 155.69 | Sell |
50 | 160.95 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 175.24 |
Resistance L2 | 171.54 |
Resistance L1 | 169.39 |
Pivot Point | 165.69 |
Support L1 | 163.54 |
Support L2 | 159.84 |
Support L3 | 157.69 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.